A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Rivaroxaban

Need help?
media.product.imagealternatetextformat.details

Rivaroxaban Impurity 76

N° de SZ CAT: SZ-R017126
Número CAS
19667-37-9
Mol.F.
C11H10ClNO3
Peso Molecular
239.7
Status de Fatura
In Stock
Shipping Condition Room Temperature

Nome Químico: 2-(3-Chloro-2-hydroxypropyl)isoindoline-1,3-dione

Shipping Temperature: Room Temperature

HSN Code: 38229010

Country of Origin: India

Sorrisos: O=C(N1CC(O)CCl)C(C=CC=C2)=C2C1=O

Rivaroxaban Impurity 76 is chemically 2-(3-Chloro-2-hydroxypropyl)isoindoline-1,3-dione. Rivaroxaban Impurity 76 is supplied with detailed characterization data compliant with regulatory guideline. Rivaroxaban Impurity 76 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Rivaroxaban.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

🔍

Search by Keywords

Buy 19667-37-9 Purchase 19667-37-9 Order 19667-37-9 Enquire 19667-37-9 Price of 19667-37-9 19667-37-9 Supplier 19667-37-9 Manufacturer 19667-37-9 Exporter Buy high quality Rivaroxaban Impurity 76 Purchase Rivaroxaban Impurity 76 Rivaroxaban Impurity 76 suppliers Rivaroxaban Impurity 76 manufacturers Rivaroxaban Impurity 76 price Rivaroxaban Impurity 76 exporter Order Rivaroxaban Impurity 76 Enquire Rivaroxaban Impurity 76 Rivaroxaban Impurity 76 cost Rivaroxaban Impurity 76 Supplier Rivaroxaban Impurity 76 Distributor
ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new development or finding in product specification without further noticed.

,